Lisa Von Moltke

Lisa Von Moltke is currently serving as the Executive Vice President and Chief Medical Officer. She earned her Bachelor of Arts from Wellesley College and received her Medical Degree from Michigan State University, College of Human Medicine. Von Moltke’s career in the pharmaceutical industry includes significant positions at Alkermes, Inc., where she advanced to Senior Vice President and Head of Clinical Development. Prior to that, she was at Sanofi/Genzyme Corporation, initially serving as Vice President Clinical Pharmacology and U.S. Head Clinical & Exploratory Pharmacology Sciences (CEP). She later expanded her role to include Head of CEP for the Japan and China regions. Additionally, Von Moltke has contributed to the field of oncology as the Head of Translational Medicine at the Takeda Oncology Company. Her leadership extends to academic and professional organizations, having served as President of the American College of Clinical Pharmacology and as the Editor-in-Chief of The Journal of Clinical Pharmacology. Her extensive background and leadership roles underscore her significant contributions to clinical pharmacology and drug development.